ArticleMucosal immunology2026
MDA5-MAVS and interferon-lambda signaling in the intestinal epithelium limit murine astrovirus infection.
Article in Mucosal immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The gut virome and regulatory T cell axis in health and systemic disease.Microbiome research reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Human astroviruses (HAstVs) are a global cause of pediatric gastroenteritis and can cause disseminated infection in immunocompromised hosts. Murine astrovirus (muAstV) causes acute asymptomatic infections in immunocompetent mice and chronic infection in immunodeficient models and has provided important insights into AstV pathogenesis in vivo. MuAstV can protect immunodeficient mice from other enteric viruses via robust induction of antiviral cytokine interferon-lambda (IFN-λ), with recent findings implicating goblet cells and enterocytes as both cell types infected by muAstV as well as potential sources of IFN-λ in vivo. However, the viral sensing pathways that regulate induction of IFN-λ, as well as the specific activity of IFN-λ in viral control and regulation of cellular tropism, remain to be defined for muAstV. Here, we leveraged single-cell RNA sequencing (scRNA-seq) to provide additional evidence of muAstV tropism for multiple intestinal epithelial cells (IECs) including goblet cells and diverse enterocyte types. Significantly, enterocytes appear to serve as the dominant source of IFN-λ in response to muAstV infection. Moreover, we report that this induction of IFN-λ in response to muAstV is regulated by the MDA5-MAVS pathway, with enhanced infection and expansion of infected cell numbers observed when either Mda5 or Mavs is disrupted. Leveraging mice conditionally deficient for Ifnlr1 or Mavs, we characterized the specific cellular requirements for IFN-λ signaling and MAVS to control muAstV infection. While IFN-λ signaling acts predominantly on secretory cells, including goblet cells, to limit muAstV infection, we found that IECs broadly require MAVS to control muAstV but with no specific IEC type implicated, suggesting a potential synergistic requirement across IECs. Our study highlights the MDA5-MAVS-IFN-λ signaling axis as critical for regulation of muAstV infection, providing further insights into the innate immune regulation of this enteric pathogen.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.